Historical position

Two Sigma Investments, LP’s Repligen Corp (RGEN) position

Reported position history, portfolio importance and verified filing changes from public SEC disclosures.

Two Sigma Investments, LPVerified through Q2 2026
Relationship snapshot

At a glance

The full verified relationship, including prior ownership episodes and exits where supported.

First reportedQ4 2021Earliest verified positive filing snapshot
Latest statusHistorical positionBased on the latest supported relationship state
Peak shares436.16KHighest verified quarter-end share count
Quarters reported7Verified quarters with shares above zero
What happened?

Two Sigma Investments, LP first reported Repligen Corp in Q4 2021. The reported position was increased and reduced across later filings. Verified positive position history runs through Q3 2025. The current relationship status cannot be determined reliably from supported data.

Verified SEC history

Position over time

See the same verified relationship through reported shares, portfolio weight or reported value.

Metric

Gaps indicate periods that cannot be safely connected or where a verified corporate action changes the raw share scale. Stock price, when available, is market context and not a transaction price.

Key filing events

What changed

Latest filing plus the most meaningful reported changes. Unchanged quarters are collapsed by default.

Q3 2025
Sold 69.7% of the position−218.28K shares · 94.86K shares remained
Filing context

Quarter-end price $133.67

Q2 2025
Bought 39.0% more+87.84K shares · 313.14K shares reported after the change
Filing context

Quarter-end price $124.38

Q1 2025
Sold 37.2% of the position−133.73K shares · 225.31K shares remained
Filing context

Quarter-end price $127.24

Q4 2024
Sold 17.7% of the position−77.12K shares · 359.04K shares remained
Filing context

Quarter-end price $143.94

Q3 2024
Bought 104.7% more+223.07K shares · 436.16K shares reported after the change
Filing context

Quarter-end price $148.82

Q2 2024
Bought 9,165.0% more+210.80K shares · 213.10K shares reported after the change
Filing context

Quarter-end price $126.06

Portfolio importance

How important was Repligen Corp in Two Sigma Investments, LP’s reported portfolio?

Relative importance is measured only within the verified primary non-option reported portfolio for each quarter.

Last reported portfolio weight0.0%Q3 2025
Last reported rank#833Rank unavailable
Peak portfolio weight0.1%Q3 2024
Best historical rank#175Q3 2024
SEC evidence & methodology

SEC filing evidence

Market context and filing-derived values are kept separate from actual transaction prices, which 13F filings do not disclose.

Latest verified stock price$186.752026-09-22

Market context only; not an investor transaction price.

Latest filing quarter-end price$133.67Q3 2025

Derived from validated reported value and shares where supported.

Latest verified investor filingQ2 2026 · filed 2026-08-14
Open SEC filing ↗

Coverage is bounded to the institution’s top reported positions and material events rather than every security in each Form 13F. The filing reflects reportable U.S.-listed holdings, not Two Sigma’s complete trading book, models, short positions, exact trade dates or execution prices. Options are reported separately.